Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007674. doi: 10.1101/cshperspect.a007674.

Generating β cells from stem cells-the story so far.

Author information

  • Diabetes Center, Department of Medicine, University of California, San Francisco, San Francisco, California, USA. mhebrok@diabetes.ucsf.edu

Abstract

Despite intensive research, a treatment for diabetic patients that completely restores normoglycemia for an indefinite period of time remains elusive. Although islet transplantation temporarily confers normoglycemia to patients, the lack of a renewable source of insulin-producing β cells hampers the use of this treatment option. Although significant hurdles remain, recent advances in stem cell biology indicate that generation of fully matured β cells from uncommitted progenitor cells, including human embryonic stem cells and induced pluripotent stem cells derived from somatic cell populations, is becoming an achievable goal.

PMID:
22675664
[PubMed - indexed for MEDLINE]
PMCID:
PMC3367541
Free PMC Article

Images from this publication.See all images (2)Free text

Figure 1.
Figure 2.
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk